Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health-Global Health, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
Infection. 2024 Oct;52(5):2083-2095. doi: 10.1007/s15010-024-02310-0. Epub 2024 Jul 2.
Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken.
治疗期间结核病(TB)治疗的矛盾反应(PR)很常见,但也有治疗后描述的情况。治愈或完成先前治疗后出现 TB 的复发症状或体征需要与微生物学复发和矛盾反应区分开来。我们搜索了所有关于治疗后 PR 的已发表文献,并综合了 30 项研究,重点介绍了这种现象的流行病学、诊断和管理。我们报告了一个额外的病例。大多数研究是淋巴结结核病(LN-TB),其次是中枢神经系统结核病(CNS-TB)。共报告了 112 例确诊和 42 例可能的治疗后 PR 病例。LN-TB 的发病率在 3%至 14%之间,比复发更频繁,所有结核病的发病率在 0%至 2%之间。我们发现了 4 例治疗后 PR 的肺或胸膜结核病病例。发病率与治疗时间无关,但与初始诊断时年龄较小以及(以后)在治疗期间发生 PR 有关。治疗后 PR 主要发生在 TB 治疗结束后 6 个月内,但也有报告称多年后(最长报告为 10 年)发生。诊断和管理的主要依据分别是阴性分枝杆菌培养和抗炎治疗。由于 LN-TB 复发性症状的预后良好,需要进行短期观察以评估自发消退的可能性。对于 CNS-TB 伴有复发性症状,应立即进行调查并进行抗炎治疗,可能需要重新治疗结核病。